3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Sebaceous Cell Tumor of Eyelid
1
Prostatic Neoplasms
1
Prostate cancer, familial
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Lung Squamous Cell Carcinoma
1
Genetic Predisposition to Disease
1
Breast Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Bevacizumab
5
Everolimus
4
Sirolimus
2
Lapatinib
2
vistusertib
1
temsirolimus
1
neratinib
1
icotinib
1
brigatinib
1
Vascular Endothelial Growth Factor A
1
Valproic Acid
1
Sunitinib
1
Immunoglobulin G
1
HDAC-42
1
Exome
1
Endostatins
1
Doxycycline
1
Disulfides
1
Crizotinib
1
Cetuximab
1
Axitinib
1
Aspirin
1
AZD 6244
1
89Zr-bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neurofibromatosis 2
×
Exome
×
Clear all
NCT03210285
2018-07-23
NF2
University Hospital Tuebingen
Completed
70 enrolled